InspireMD, Inc.
InspireMD, Inc. (NSPR) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · NSPR · as of Jun 9, 2026
Key Statistics
Explore InspireMD, Inc. Data
nspr stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 7 · Buy rate: 85.7%
The NSPR analyst consensus is Buy, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month price target is $4.50, representing +451.27% upside from the current price of $0.82.
Competitors & Peers
nspr competitorsNSPR
CNTX
EDAP
FONR
HYPR
IMAStock Performance
Full HistoryAbout InspireMD, Inc.
InspireMD, Inc. an Israel-based medical technology company established in 2005, specializes in creating and commercializing advanced medical devices. Its core expertise lies in the proprietary MicroN…
what is inspiremd, inc. · nspr stock overview · inspiremd, inc. company profile · who is inspiremd, inc. ceo · nspr NASDAQ · inspiremd, inc. headquarters · inspiremd, inc. business segments
About Stock Overview & Key Data
InspireMD, Inc. (NSPR) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Apr 12, 2011. As of the latest trading session, NSPR stock price is $0.82, with a market capitalization of $38.2M. The stock has returned -65.99% over the past 12 months and -54.14% year-to-date.
According to 7 Wall Street analysts, the consensus rating for InspireMD, Inc. stock is Buy, with an average 12-month price target of $4.50. In fiscal year 2025, InspireMD, Inc. reported revenue of $9.0M and net income of -$48.8M. For detailed data — including InspireMD, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, InspireMD, Inc. (NSPR) stock price is $0.82. The stock is traded on NASDAQ under the ticker symbol NSPR. The 52-week range is $0.80 – $2.93.